Takashi Kei Kishimoto - Jan 5, 2022 Form 4 Insider Report for SELECTA BIOSCIENCES INC (SELB)

Role
Chief Scientific Officer
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Takashi Kei Kishimoto
Stock symbol
SELB
Transactions as of
Jan 5, 2022
Transactions value $
-$10,541
Form type
4
Date filed
1/7/2022, 03:18 PM
Previous filing
Jan 5, 2022
Next filing
Jan 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SELB Common Stock Sale -$10.5K -3.42K -1.26% $3.09 268K Jan 5, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.
F2 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.99 to $3.17. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.